Hypofractionated Radiation Therapy for Prostate Cancer

 

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]

 

Learn More

 

 

Treatment When Active Surveillance Is Not Enough

 

If you have been diagnosed with low-risk prostate cancer, it is likely you know about active surveillance, a passive form of treatment that started to grow in popularity in 2010. By 2015, 42.1% of low-risk prostate cancer patients opted for getting regular PSA tests, biopsies, and imaging tests instead of a more aggressive treatment plan. […]

 

Learn More

 

 

Prostate Cancer: Shawn’s Story

 

Watch and listen to CyberKnife patient, Shawn, and board-certified radiation oncologist and St. Louis CyberKnife Medical Director, John Bedwinek, M.D., talk about how the CyberKnife system treats cancer.

 

Learn More

 

 

Dr. Bedwinek Discusses Prostate Cancer on Show Me St. Louis

 

Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.

 

Learn More

 

 

Dr. Bedwinek Discusses Prostate Cancer on Show Me St. Louis

 

Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.

 

Learn More

 

 

Dr. Morris Discusses Prostate Cancer on Great Day Saint Louis

 

David Morris, M.D., Radiation Oncologist and Medical Director at St. Louis CyberKnife, was a guest on Great Day Saint Louis. Watch Dr. Morris discuss prostate cancer (risk factors, signs and symptoms, current stats, etc.) and the benefits of treating it with CyberKnife technology.

 

Learn More

 

 

Studies Show CyberKnife Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions

 

Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer.  The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]

 

Learn More

 

 

Prostate Cancer Treatment’s Impact on Sexual Function

 

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and […]

 

Learn More

 

 

Thank You Letter

 

A recent patient treated at St. Louis CyberKnife wrote a thank you letter to the staff and physicians at our center to express their sincerest gratitude to everyone who assisted with their care.  Please take a moment to read the thoughtful and kind words our former patient had to say about his CyberKnife experience. Admittedly, […]

 

Learn More

 

 

10-year Data Shows CyberKnife Provides Excellent Long-term Control of Low-Risk Prostate Cancer

 

Accuray, the company that develops and manufactures the CyberKnife® Robotic Radiosurgery System, the system that St. Louis CyberKnife uses to treat cancer, recently announced the results of the first study that evaluated the use of stereotactic body radiation therapy (SBRT) in low-risk prostate cancer 10 years post treatment. The study titled, “Stereotactic Body Radiotherapy for […]

 

Learn More